PRGOPerrigo Company plc
What is the market doing?
No clear lean: in an uptrend, but a crowded short (+16% of shares).
In an uptrend, above its rising 50- and 200-day averages. Price is +23% vs its 200-day average.
A crowded short, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How PRGO is trading
Perrigo Company plc is −26% over the past year while the S&P 500 is +18%: 44 points behind the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +23%
vs 200-day average · a clear uptrend
- RSI (14)
- 58
RSI (14) · neutral
- Below its 52-week high
- 30%
Below its 52-week high
Details›
- Last close2026-10-09
- $15.05
- 1 monthS&P 500 +2.7%
- +11%
- 1 yearS&P 500 +18%
- −26%
- 5 yearsS&P 500 +88%
- −61%
- vs 50-day average$13.69
- +9.9%
- 52-week high
- $21.46
- 52-week low
- $9.02
- Annualised volatility
- 47%
| Year | Return |
|---|---|
| 2026 (year to date) | +13% |
| 2025 | −44% |
| 2024 | −17% |
| 2023 | −2.5% |
| 2022 | −9.8% |
| 2021 | −11% |
| 2020 | −12% |
| 2019 | +36% |
| 2018 | −55% |
| 2017 | +5.6% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 5 of 10 | +2.8% |
| Feb | 10 | 3 of 10 | −3.7% |
| Mar | 10 | 4 of 10 | −0.52% |
| Apr | 10 | 6 of 10 | +1.5% |
| May | 10 | 4 of 10 | −1.7% |
| Jun | 10 | 5 of 10 | +0.77% |
| Jul | 11 | 8 of 11 | +4.7% |
| Aug | 11 | 3 of 11 | −0.56% |
| Sep | 11 | 5 of 11 | −0.30% |
| Oct | 11 | 2 of 11 | −3.3% |
| Nov | 10 | 5 of 10 | −4.3% |
| Dec | 10 | 5 of 10 | −3.5% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #23 of 41 by RyuScore